Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 16 | 13 | -0,64 % | ||
| XENCOR | 8 | - | 0,00 % | ||
| AMGEN | 6 | 27 | -0,19 % | ||
| MODERNA | 6 | 16 | -2,04 % | ||
| INCYTE | 5 | 25 | -0,05 % | ||
| ORUKA THERAPEUTICS | 5 | - | +1,23 % | ||
| SUMMIT THERAPEUTICS | 4 | 12 | 0,00 % | ||
| ACLARIS THERAPEUTICS | 4 | 1 | -14,49 % | ||
| AARDVARK THERAPEUTICS | 4 | - | +0,46 % | ||
| REGENERON PHARMACEUTICALS | 3 | 22 | +0,93 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:54 | Neurogene presents preclinical data on Rett syndrome therapy | 2 | Investing.com | ||
| 12:51 | Wave Life Sciences, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12:42 | BTIG raises Guardant Health stock price target on growth outlook | 2 | Investing.com | ||
| 12:42 | Kiniksa Pharmaceuticals International, plc GAAP EPS of $0.56 beats by $0.21, revenue of $286M beats by $25.39M | 3 | Seeking Alpha | ||
| 12:38 | Wave Life Sciences Ltd. Q3 Sales Increase | 4 | RTTNews | ||
| 12:36 | Wave Life Sciences Ltd.: Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update | 3 | GlobeNewswire (USA) | ||
| 12:36 | Wave Life Sciences GAAP EPS of -$0.30 beats by $0.03, revenue of $13.16M beats by $8.77M | 7 | Seeking Alpha | ||
| 12:36 | Wave Life Sciences, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 12:34 | Bewertungsbedenken nach Kursrallye: William Blair stuft Moderna ab | 5 | Investing.com Deutsch | ||
| 12:30 | William Blair downgrades Moderna stock rating on valuation concerns | 7 | Investing.com | ||
| 12:10 | Aclaris preist Kapitalerhöhung über 50 Mio. $ zu 3,50 $ je Aktie ein | 2 | Investing.com Deutsch | ||
| 12:06 | Vanda reports positive trial results for GLP-1 vomiting drug | 2 | Investing.com | ||
| 12:06 | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics to Report Third Quarter 2026 Financial Results and Corporate Updates on Thursday, November 5, 2026 | 1 | GlobeNewswire (USA) | ||
| 12:06 | Arvinas Inc.: Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026 | 1 | GlobeNewswire (USA) | ||
| 12:06 | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA | 1 | GlobeNewswire (USA) | ||
| 12:02 | Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026 | 154 | ACCESS Newswire | NEWARK, CA / ACCESS Newswire / October 27, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that senior management will participate in four investment bank... ► Artikel lesen | |
| 11:50 | Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS (tradipitant) for Prevention of GLP-1-Induced Vomiting | 35 | PR Newswire | .release-content span.prnews_span{font-size:8pt;font-family:"Arial";color:black}.release-content a.prnews_a{color:blue}.release-content li.prnews_li{font-size:8pt;font-family:"Arial";color:black}.release-content... ► Artikel lesen | |
| 11:48 | Aclaris Therapeutics, Inc.: Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants | 3 | GlobeNewswire (USA) | ||
| 11:46 | Regeneron agrees to $270m extension to supply Ebola medicine in US | 5 | Pharmaceutical Technology | ||
| 11:46 | Wells Fargo erhöht Kursziel für Xencor nach positiven Nierenkrebs-Daten | 5 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.